Search

Agnieszka Boesen

Examiner (ID: 5487, Phone: (571)272-8035 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1648, 1672
Total Applications
1076
Issued Applications
632
Pending Applications
101
Abandoned Applications
361

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18694001 [patent_doc_number] => 20230324404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/999192 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999192 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999192
METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES May 18, 2021 Abandoned
Array ( [id] => 18559958 [patent_doc_number] => 11725194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Hepatitis B virus (HBV) vaccines and uses thereof [patent_app_type] => utility [patent_app_number] => 17/324494 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 35346 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324494 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/324494
Hepatitis B virus (HBV) vaccines and uses thereof May 18, 2021 Issued
Array ( [id] => 17065889 [patent_doc_number] => 20210268104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV) [patent_app_type] => utility [patent_app_number] => 17/323082 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/323082
Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV) May 17, 2021 Abandoned
Array ( [id] => 19235010 [patent_doc_number] => 20240192204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => A DEVICE AND ASSAYS FOR DETECTION OF PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/998556 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998556 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998556
A DEVICE AND ASSAYS FOR DETECTION OF PATHOGENS May 16, 2021 Pending
Array ( [id] => 19275499 [patent_doc_number] => 12025622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Use and treatment of di-amino acid repeat-containing proteins associated with ALS [patent_app_type] => utility [patent_app_number] => 17/322604 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 23202 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322604 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322604
Use and treatment of di-amino acid repeat-containing proteins associated with ALS May 16, 2021 Issued
Array ( [id] => 17482265 [patent_doc_number] => 20220089769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/320046 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320046 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320046
REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES May 12, 2021 Abandoned
Array ( [id] => 17228614 [patent_doc_number] => 20210355170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => Stabilizing Mutants of Prefusion Sars-Cov-2 (Covid-19) Spike Protein And Improved Yeast Surface Display Engineering Platform For The Same [patent_app_type] => utility [patent_app_number] => 17/318719 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318719 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/318719
Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same May 11, 2021 Issued
Array ( [id] => 17052193 [patent_doc_number] => 20210261627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE [patent_app_type] => utility [patent_app_number] => 17/316834 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31407 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316834 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/316834
Respiratory syncytial virus (RSV) vaccine May 10, 2021 Issued
Array ( [id] => 17185561 [patent_doc_number] => 20210332446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS [patent_app_type] => utility [patent_app_number] => 17/240858 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13331 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240858 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/240858
ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS Apr 25, 2021 Abandoned
Array ( [id] => 19827178 [patent_doc_number] => 12247950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Virus detection system, virus detection method, and virus detection program [patent_app_type] => utility [patent_app_number] => 17/236516 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 6331 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236516 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/236516
Virus detection system, virus detection method, and virus detection program Apr 20, 2021 Issued
Array ( [id] => 17343982 [patent_doc_number] => 20220010313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS [patent_app_type] => utility [patent_app_number] => 17/234145 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234145 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/234145
CRISPR/CAS-related methods and compositions for treating herpes simplex virus Apr 18, 2021 Issued
Array ( [id] => 18437470 [patent_doc_number] => 20230184765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => DETECTION ASSAYS FOR CORONAVIRUS NEUTRALIZING ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/919133 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -178 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919133 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919133
Detection assays for coronavirus neutralizing antibodies Apr 18, 2021 Issued
Array ( [id] => 17823750 [patent_doc_number] => 11428694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies [patent_app_type] => utility [patent_app_number] => 17/231782 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 41571 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231782
Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies Apr 14, 2021 Issued
Array ( [id] => 18597572 [patent_doc_number] => 20230272368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 17/919100 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919100 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919100
PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID Apr 13, 2021 Abandoned
Array ( [id] => 19332893 [patent_doc_number] => 20240247323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => MULTIPLEXED PCR ASSAY WITH POINT OF CARE SAMPLE [patent_app_type] => utility [patent_app_number] => 17/918802 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918802
MULTIPLEXED PCR ASSAY WITH POINT OF CARE SAMPLE Apr 12, 2021 Pending
Array ( [id] => 20848747 [patent_doc_number] => 12685764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-21 [patent_title] => Universal influenza vaccine using nucleoside-modified mRNA [patent_app_type] => utility [patent_app_number] => 17/995207 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 97 [patent_no_of_words] => 55642 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995207 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995207
Universal Influenza Vaccine Using Nucleoside-Modified mRNA Mar 30, 2021 Issued
Array ( [id] => 20716387 [patent_doc_number] => 12631629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-19 [patent_title] => Device and methods for rapid detection of target analytes in a biological sample [patent_app_type] => utility [patent_app_number] => 17/907109 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 34 [patent_no_of_words] => 14692 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907109 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907109
Device and methods for rapid detection of target analytes in a biological sample Mar 30, 2021 Issued
Array ( [id] => 18675701 [patent_doc_number] => 20230313323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => ASSAYS FOR DETECTING CORONAVIRUS DISEASE 2019 (COVID-19) [patent_app_type] => utility [patent_app_number] => 17/906542 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906542 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906542
ASSAYS FOR DETECTING CORONAVIRUS DISEASE 2019 (COVID-19) Mar 25, 2021 Pending
Array ( [id] => 18470282 [patent_doc_number] => 20230204567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHOD FOR DETERMINING THE POTENCY OF ANTIGENS [patent_app_type] => utility [patent_app_number] => 17/999131 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999131 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999131
METHOD FOR DETERMINING THE POTENCY OF ANTIGENS Mar 18, 2021 Abandoned
Array ( [id] => 17141954 [patent_doc_number] => 20210309966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => METHODS OF IMPROVING VECTOR TRANSDUCTION EFFICIENCY INTO T LYMPHOCYTES [patent_app_type] => utility [patent_app_number] => 17/200745 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200745 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/200745
Methods of improving vector transduction efficiency into T lymphocytes Mar 11, 2021 Issued
Menu